Our new study is published in Cell Reports:

Dahiya UR, Kumari S, Singh N, Rawat C, Cortes E, Ghanem Y, Corey E, Dehm SM, Willard B, Alshalalfa M, Davicioni E, McKenney J, Weight C, Haywood SC, Liu S, Liu T, Heemers HV. Disrupting the interaction between androgen receptor and its coregulator WDR77 delays the growth of treatment-resistant prostate cancer.